Breaking News: Lexicon’s Public Offering and Private Placement Fully Exercised and Closed – Don’t Miss Out!
Lexicon Pharmaceuticals Announces Additional Shares Issuance The Woodlands, Texas Aug. 05, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) Lexicon Pharmaceuticals, Inc. made a significant announcement today regarding the issuance and sale of an additional 2,526,540 shares of its common stock. The underwriters have exercised their option to purchase additional shares in connection with…